IGEA Pharma NV
SIX:IGPH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Jiangsu Leike Defense Technology Co Ltd
SZSE:002413
|
CN |
|
Colt CZ Group SE
OTC:CZGZF
|
CZ |
IGEA Pharma NV
Common Stock
IGEA Pharma NV
Common Stock Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Common Stock | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
IGEA Pharma NV
SIX:IGPH
|
Common Stock
€3.4m
|
CAGR 3-Years
128%
|
CAGR 5-Years
72%
|
CAGR 10-Years
N/A
|
|
|
O
|
ONWARD Medical NV
XBRU:ONWD
|
Common Stock
€6.7m
|
CAGR 3-Years
23%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
IGEA Pharma NV
Glance View
IGEA Pharma NV is a health-tech company focused on measure and control of test factors related to life-threatening diseases. The company is headquartered in Hoofddorp, Noord-Holland. The company went IPO on 2018-12-20. The firm focuses on research and development of biomedical solutions for the prevention of diabetes and Alzheimer's disease. Its offering portfolio includes medical testing devices and dietary supplements. The firm develops ALZ-1 Test, a blood test to measure and control level of free copper, also known as Free Copper II or Non-Ceruloplasmin Copper in the bloodstream, which is a major recognized modifiable risk factor for the Alzheimer’s disease. The firm offers its services in the Netherlands.
See Also
What is IGEA Pharma NV's Common Stock?
Common Stock
3.4m
EUR
Based on the financial report for Dec 31, 2022, IGEA Pharma NV's Common Stock amounts to 3.4m EUR.
What is IGEA Pharma NV's Common Stock growth rate?
Common Stock CAGR 5Y
72%
Over the last year, the Common Stock growth was 1%. The average annual Common Stock growth rates for IGEA Pharma NV have been 128% over the past three years , 72% over the past five years .
